Review




Structured Review

Ribobio co ribofect cp transfection kit (166t)
Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the <t>transfection</t> efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).
Ribofect Cp Transfection Kit (166t), supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ribofect+cp+transfection+kit/ribofect+cp+transfection+kit/pmc12198005-45-17-22
Average 90 stars, based on 1 article reviews
ribofect cp transfection kit (166t) - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4"

Article Title: AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4

Journal: Bioactive Materials

doi: 10.1016/j.bioactmat.2025.06.013

Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).
Figure Legend Snippet: Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).

Techniques Used: Over Expression, Quantitative RT-PCR, Immunofluorescence, Biomarker Discovery, Transfection, Plasmid Preparation, CCK-8 Assay, Wound Healing Assay, Migration, Flow Cytometry, Staining, Fluorescence, Two Tailed Test

Knockdown of OLFM4 reversed the protective effect of miR-192-5p knockdown on HaCaTs function under oxidative stress model. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of OLFM4 small interfering RNA (siRNA) (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 knockdown on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 knockdown on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 knockdown on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after miR-192-5p and OLFM4 knockdown (scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after knockdown of miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).
Figure Legend Snippet: Knockdown of OLFM4 reversed the protective effect of miR-192-5p knockdown on HaCaTs function under oxidative stress model. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of OLFM4 small interfering RNA (siRNA) (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 knockdown on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 knockdown on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 knockdown on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after miR-192-5p and OLFM4 knockdown (scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after knockdown of miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).

Techniques Used: Knockdown, Quantitative RT-PCR, Immunofluorescence, Biomarker Discovery, Transfection, Small Interfering RNA, CCK-8 Assay, Wound Healing Assay, Migration, Flow Cytometry, Staining, Fluorescence, Two Tailed Test

Preparation and characterization of miR-192-5p engineered exosomes. A. TEM images of Exo-ant-192 and MSC-derived exosomes (scale bar: 100 nm). B. Particle size distribution of Exo-ant-192 and MSC-derived exosomes. C. Expression of exosome protein markers (CD81, HSP70, and TSG101) and an intracellular marker (Calnexin). D. Internalization of Exo-ant-192 and MSC-derived exosomes by HaCaTs (scale bar: 50 μm). E. Loading efficiency of Exo-Cy3-ant-192 (n = 3). F. RT-qPCR detection of intracellular miR-192-5p expression changes after transfection with Exo-ant-192 (n = 3). G. CCK8 assay to evaluate the effect of Exo-ant-192 on HaCaTs cell viability (n = 3). H and I. Effect of Exo-ant-192 on HaCaTs migration ability (scale bar: 500 μm, n = 3). J and K. Flow cytometry assessment of the effect of Exo-ant-192 on HaCaTs apoptosis (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, by two-tailed unpaired Student's t -test (E, F, G, I and K).
Figure Legend Snippet: Preparation and characterization of miR-192-5p engineered exosomes. A. TEM images of Exo-ant-192 and MSC-derived exosomes (scale bar: 100 nm). B. Particle size distribution of Exo-ant-192 and MSC-derived exosomes. C. Expression of exosome protein markers (CD81, HSP70, and TSG101) and an intracellular marker (Calnexin). D. Internalization of Exo-ant-192 and MSC-derived exosomes by HaCaTs (scale bar: 50 μm). E. Loading efficiency of Exo-Cy3-ant-192 (n = 3). F. RT-qPCR detection of intracellular miR-192-5p expression changes after transfection with Exo-ant-192 (n = 3). G. CCK8 assay to evaluate the effect of Exo-ant-192 on HaCaTs cell viability (n = 3). H and I. Effect of Exo-ant-192 on HaCaTs migration ability (scale bar: 500 μm, n = 3). J and K. Flow cytometry assessment of the effect of Exo-ant-192 on HaCaTs apoptosis (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, by two-tailed unpaired Student's t -test (E, F, G, I and K).

Techniques Used: Derivative Assay, Expressing, Marker, Quantitative RT-PCR, Transfection, CCK-8 Assay, Migration, Flow Cytometry, Two Tailed Test

Related Articles

Synthesized:

Article Title: Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin/GPX4-Mediated Ferroptosis
Article Snippet: The cells were grown in Dulbecco’s modified Eagle’s medium (Gibco, USA) or minimum essential medium (Gibco, USA) supplemented with 10% fetal bovine serum at 5% CO 2 , 37 °C. .. The hsa_piR_016975 mimics (mi-016975) and its inhibitors (in-016975) were synthesized and transfected using the RiboFECT CP Transfection Kit (RiboBio, China). .. Si-Maspin and its overexpressed vectors were constructed (GenePharma, China) and transfected using Lipofectamine 3000 (Invitrogen, USA).

Transfection:

Article Title: Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin/GPX4-Mediated Ferroptosis
Article Snippet: The cells were grown in Dulbecco’s modified Eagle’s medium (Gibco, USA) or minimum essential medium (Gibco, USA) supplemented with 10% fetal bovine serum at 5% CO 2 , 37 °C. .. The hsa_piR_016975 mimics (mi-016975) and its inhibitors (in-016975) were synthesized and transfected using the RiboFECT CP Transfection Kit (RiboBio, China). .. Si-Maspin and its overexpressed vectors were constructed (GenePharma, China) and transfected using Lipofectamine 3000 (Invitrogen, USA).

Article Title: USP10 Inhibits Ferroptosis via Deubiquinating POLR2A in Head and Neck Squamous Cell Carcinoma.
Article Snippet: .. Transient silencing of POLR2A was performed using a riboFECT CP Transfection Kit (Ribobio, C1051105; Guangzhou, China). .. Subsequently, ultrathin sections were stained with uranyl acetate or lead citrate, ultimately followed by the observation with JEOL 1200EX transmission electron microscopy (JEOL Ltd. Japan).

Article Title: Combination of Astragalus−Salvia and Ophiopogon−Dendrobium herb pairs alleviates Sjögren’s Syndrome via inhibiting the JAK1/STAT3 and PI3K/AKT pathways in NOD/Ltj mice
Article Snippet: .. The silencing siRNA targeting JAK1 was designed and constructed by riboFECT CP Transfection Kit (RIBOBIO, China), comprising three siRNAs, with the most effective one selected through preliminary experiments. .. Transfection complexes were prepared using the riboFECT CP Transfection Kit (RIBOBIO, China).

Article Title: Long noncoding RNA LINC01215 represses differentiation and proliferation of keratinocytes via zinc finger 652 in atopic dermatitis
Article Snippet: The primary antibodies applied for WB including FLG (#pab0545, Covalab, France), ZNF652 (#bs-7487R, Bioss, China), Caspase-3 (#bs-0081R, Bioss, China) and GAPDH (#bs-0755R, Bioss). .. Briefly, the blank pmirGLO or pmirGLO containing FLG promoter (pmirGLO-FLG) were co-transfected with LINC01215 ASO or ZNF652 ASO into HaCaT cells utilizing riboFECT CP Transfection Kit (#C1051105, RiboBio) followed by the detection of luciferase activities using Dual-luciferase Reporter Assay System (#E1910, Promega, USA). ..

Article Title: Src/FN1 pathway activation drives tumor cell cluster formation and metastasis in lung cancer: A promising therapeutic target.
Article Snippet: .. After 4 hours, the cells were transfected with 50 nM Src (#SIGS0004862) or FN1 (#SIGS0002309) siRNA via a riboFECT CP transfection kit (RiboBio, China) according to the manufacturer’s guidelines. ..

Article Title: MiR-100-5p as a biomarker in hand-arm vibration disease: Mediating pathogenesis through angiogenesis suppression.
Article Snippet: .. Transfections were performed following the manufacturer's instructions with Lipofectamine 2000 reagent (Invitrogen, CA, USA) or a riboFECT CP transfection kit (RiboBio, Guangzhou, China). ..

Article Title: Rhaponitin Reverses Cisplatin Resistance and Impairs Cancer Stemness Through HIF-1α/MCT4/Wnt Pathway in Tongue Squamous Cell Carcinoma.
Article Snippet: The pCMV6- HIF- 1α vector (HIF- 1α oe; #SR300295; OriGene, MD, USA) was used for HIF- 1α overexpression in SCC9 and SCC9- CisR cells, with the empty vector as control. .. Transfection was performed using the RiboFECT CP Transfection Kit (Ribobio, Guangzhou, China) according to the manufacturer's instructions. ..

Construct:

Article Title: Combination of Astragalus−Salvia and Ophiopogon−Dendrobium herb pairs alleviates Sjögren’s Syndrome via inhibiting the JAK1/STAT3 and PI3K/AKT pathways in NOD/Ltj mice
Article Snippet: .. The silencing siRNA targeting JAK1 was designed and constructed by riboFECT CP Transfection Kit (RIBOBIO, China), comprising three siRNAs, with the most effective one selected through preliminary experiments. .. Transfection complexes were prepared using the riboFECT CP Transfection Kit (RIBOBIO, China).

Allele-specific Oligonucleotide:

Article Title: Long noncoding RNA LINC01215 represses differentiation and proliferation of keratinocytes via zinc finger 652 in atopic dermatitis
Article Snippet: The primary antibodies applied for WB including FLG (#pab0545, Covalab, France), ZNF652 (#bs-7487R, Bioss, China), Caspase-3 (#bs-0081R, Bioss, China) and GAPDH (#bs-0755R, Bioss). .. Briefly, the blank pmirGLO or pmirGLO containing FLG promoter (pmirGLO-FLG) were co-transfected with LINC01215 ASO or ZNF652 ASO into HaCaT cells utilizing riboFECT CP Transfection Kit (#C1051105, RiboBio) followed by the detection of luciferase activities using Dual-luciferase Reporter Assay System (#E1910, Promega, USA). ..

Luciferase:

Article Title: Long noncoding RNA LINC01215 represses differentiation and proliferation of keratinocytes via zinc finger 652 in atopic dermatitis
Article Snippet: The primary antibodies applied for WB including FLG (#pab0545, Covalab, France), ZNF652 (#bs-7487R, Bioss, China), Caspase-3 (#bs-0081R, Bioss, China) and GAPDH (#bs-0755R, Bioss). .. Briefly, the blank pmirGLO or pmirGLO containing FLG promoter (pmirGLO-FLG) were co-transfected with LINC01215 ASO or ZNF652 ASO into HaCaT cells utilizing riboFECT CP Transfection Kit (#C1051105, RiboBio) followed by the detection of luciferase activities using Dual-luciferase Reporter Assay System (#E1910, Promega, USA). ..

Reporter Assay:

Article Title: Long noncoding RNA LINC01215 represses differentiation and proliferation of keratinocytes via zinc finger 652 in atopic dermatitis
Article Snippet: The primary antibodies applied for WB including FLG (#pab0545, Covalab, France), ZNF652 (#bs-7487R, Bioss, China), Caspase-3 (#bs-0081R, Bioss, China) and GAPDH (#bs-0755R, Bioss). .. Briefly, the blank pmirGLO or pmirGLO containing FLG promoter (pmirGLO-FLG) were co-transfected with LINC01215 ASO or ZNF652 ASO into HaCaT cells utilizing riboFECT CP Transfection Kit (#C1051105, RiboBio) followed by the detection of luciferase activities using Dual-luciferase Reporter Assay System (#E1910, Promega, USA). ..

other:

Article Title: Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia
Article Snippet: RNA interference NF-E2 siRNA was designed and synthesized by RiboBio Co., Ltd. (Guangzhou, China).



Similar Products

90
Ribobio co ribofect cp transfection kit (166t)
Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the <t>transfection</t> efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).
Ribofect Cp Transfection Kit (166t), supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ribofect+cp+transfection+kit/ribofect+cp+transfection+kit/pmc12198005-45-17-22
Average 90 stars, based on 1 article reviews
ribofect cp transfection kit (166t) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Ribobio co ribofect cp transfection kit c10511-05
Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the <t>transfection</t> efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).
Ribofect Cp Transfection Kit C10511 05, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ribofect+cp+transfection+kit/ribofect+cp+transfection+kit/pmc12257754-68-44-48
Average 90 stars, based on 1 article reviews
ribofect cp transfection kit c10511-05 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Ribobio co ribofect cp transfection kit
Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the <t>transfection</t> efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).
Ribofect Cp Transfection Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ribofect+cp+transfection+kit/ribofect+cp+transfection+kit/pmc10153531__2022_282209_WANG_SUPPL-54-10-14
Average 90 stars, based on 1 article reviews
ribofect cp transfection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Ribobio co ribofect tm cp transfection kit
Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the <t>transfection</t> efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).
Ribofect Tm Cp Transfection Kit, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ribofect+cp+transfection+kit/ribofect+cp+transfection+kit/pm40501119-48-1-9
Average 90 stars, based on 1 article reviews
ribofect tm cp transfection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).

Journal: Bioactive Materials

Article Title: AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4

doi: 10.1016/j.bioactmat.2025.06.013

Figure Lengend Snippet: Overexpression of OLFM4 protected HaCaTs from dysfunction induced by miR-192-5p overexpression. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of the OLFM4 overexpression plasmid (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 overexpression on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 overexpression on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 overexpression on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after overexpressing miR-192-5p and OLFM4(scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after overexpressing miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).

Article Snippet: HaCaTs were transfected with NC mimic, miR-192-5p mimic, NC inhibitor or miR-192-5p inhibitor (Accurate Biology, China) using riboFECT CP Transfection Kit (166T) (RiboBio, China) according to the manufacturer's instructions.

Techniques: Over Expression, Quantitative RT-PCR, Immunofluorescence, Biomarker Discovery, Transfection, Plasmid Preparation, CCK-8 Assay, Wound Healing Assay, Migration, Flow Cytometry, Staining, Fluorescence, Two Tailed Test

Knockdown of OLFM4 reversed the protective effect of miR-192-5p knockdown on HaCaTs function under oxidative stress model. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of OLFM4 small interfering RNA (siRNA) (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 knockdown on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 knockdown on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 knockdown on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after miR-192-5p and OLFM4 knockdown (scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after knockdown of miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).

Journal: Bioactive Materials

Article Title: AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4

doi: 10.1016/j.bioactmat.2025.06.013

Figure Lengend Snippet: Knockdown of OLFM4 reversed the protective effect of miR-192-5p knockdown on HaCaTs function under oxidative stress model. A-C. RT-qPCR and immunofluorescence validation of the transfection efficiency of OLFM4 small interfering RNA (siRNA) (scale bar: 50 μm, n = 3). D. CCK8 assay to assess the effect of miR-192-5p and OLFM4 knockdown on HaCaTs cell viability (n = 3). E and F. Scratch assay to evaluate the effect of miR-192-5p and OLFM4 knockdown on HaCaTs migration ability (scale bar: 500 μm, n = 3). G and H. Flow cytometry analysis of the effect of miR-192-5p and OLFM4 knockdown on HaCaTs apoptosis (n = 3). I. ROS staining fluorescence images after miR-192-5p and OLFM4 knockdown (scale bar: 50 μm). J-K. Flow cytometry assessment of ROS levels in HaCaTs after knockdown of miR-192-5p and OLFM4 (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, and ns, no significance, by two-tailed unpaired Student's t -test (A and C), and by one-way ANOVA followed by the Tukey-Kramer's post hoc test (D, F, H and K).

Article Snippet: HaCaTs were transfected with NC mimic, miR-192-5p mimic, NC inhibitor or miR-192-5p inhibitor (Accurate Biology, China) using riboFECT CP Transfection Kit (166T) (RiboBio, China) according to the manufacturer's instructions.

Techniques: Knockdown, Quantitative RT-PCR, Immunofluorescence, Biomarker Discovery, Transfection, Small Interfering RNA, CCK-8 Assay, Wound Healing Assay, Migration, Flow Cytometry, Staining, Fluorescence, Two Tailed Test

Preparation and characterization of miR-192-5p engineered exosomes. A. TEM images of Exo-ant-192 and MSC-derived exosomes (scale bar: 100 nm). B. Particle size distribution of Exo-ant-192 and MSC-derived exosomes. C. Expression of exosome protein markers (CD81, HSP70, and TSG101) and an intracellular marker (Calnexin). D. Internalization of Exo-ant-192 and MSC-derived exosomes by HaCaTs (scale bar: 50 μm). E. Loading efficiency of Exo-Cy3-ant-192 (n = 3). F. RT-qPCR detection of intracellular miR-192-5p expression changes after transfection with Exo-ant-192 (n = 3). G. CCK8 assay to evaluate the effect of Exo-ant-192 on HaCaTs cell viability (n = 3). H and I. Effect of Exo-ant-192 on HaCaTs migration ability (scale bar: 500 μm, n = 3). J and K. Flow cytometry assessment of the effect of Exo-ant-192 on HaCaTs apoptosis (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, by two-tailed unpaired Student's t -test (E, F, G, I and K).

Journal: Bioactive Materials

Article Title: AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4

doi: 10.1016/j.bioactmat.2025.06.013

Figure Lengend Snippet: Preparation and characterization of miR-192-5p engineered exosomes. A. TEM images of Exo-ant-192 and MSC-derived exosomes (scale bar: 100 nm). B. Particle size distribution of Exo-ant-192 and MSC-derived exosomes. C. Expression of exosome protein markers (CD81, HSP70, and TSG101) and an intracellular marker (Calnexin). D. Internalization of Exo-ant-192 and MSC-derived exosomes by HaCaTs (scale bar: 50 μm). E. Loading efficiency of Exo-Cy3-ant-192 (n = 3). F. RT-qPCR detection of intracellular miR-192-5p expression changes after transfection with Exo-ant-192 (n = 3). G. CCK8 assay to evaluate the effect of Exo-ant-192 on HaCaTs cell viability (n = 3). H and I. Effect of Exo-ant-192 on HaCaTs migration ability (scale bar: 500 μm, n = 3). J and K. Flow cytometry assessment of the effect of Exo-ant-192 on HaCaTs apoptosis (n = 3). Data are shown as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, by two-tailed unpaired Student's t -test (E, F, G, I and K).

Article Snippet: HaCaTs were transfected with NC mimic, miR-192-5p mimic, NC inhibitor or miR-192-5p inhibitor (Accurate Biology, China) using riboFECT CP Transfection Kit (166T) (RiboBio, China) according to the manufacturer's instructions.

Techniques: Derivative Assay, Expressing, Marker, Quantitative RT-PCR, Transfection, CCK-8 Assay, Migration, Flow Cytometry, Two Tailed Test